Life-2023-02 Esophagogastric Variceal Bleeding
NCT06011980 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2023-08-25
Summary
Study on the efficacy of the growth inhibitors after endoscopic treatment of acute esophagogastric variceal bleeding
Conditions
- Acute Esophageal Variceal Hemorrhage
Interventions
- DRUG
-
Growth Inhibitor
growth inhibitors for 250-500μg/h, ivgtt. for 5 days
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-31
- Primary Completion
- 2026-05-10
- Completion
- 2026-08-10
Countries
- China
More Related Trials
-
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
NCT02556021 ·Status: COMPLETED ·Phase: PHASE3
-
Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease
NCT03223116 ·Status: UNKNOWN ·Phase: NA
-
Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen City
NCT06585176 ·Status: COMPLETED
-
A Study on Vonoprazan in the Real-world Clinical Practice in China
NCT04501627 ·Status: COMPLETED
-
Impact of GERD on Daily Life (NIS)
NCT00545883 ·Status: COMPLETED
-
A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
NCT05192538 ·Status: UNKNOWN ·Phase: NA
-
Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux
NCT00373997 ·Status: COMPLETED ·Phase: PHASE4
-
Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD
NCT02670642 ·Status: COMPLETED ·Phase: PHASE3
-
Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease
NCT00498082 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease
NCT05587322 ·Status: COMPLETED ·Phase: PHASE3
-
Outcomes for Patients With Gastro-Esophageal Reflux Disease
NCT03824548 ·Status: UNKNOWN
-
Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
NCT00786773 ·Status: COMPLETED
-
Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.
NCT02606851 ·Status: COMPLETED
-
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
NCT01022970 ·Status: COMPLETED ·Phase: PHASE2
-
Esomeprazole for Treatment of GERD in Pediatric Patients
NCT00228527 ·Status: COMPLETED ·Phase: PHASE4
-
Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD
NCT00524355 ·Status: COMPLETED
-
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand
NCT00999063 ·Status: COMPLETED
-
Anti-reflux Mucosal Ablation Therapy Randomized Sham Control Trial for Gastroesophageal Reflux Disease
NCT06106100 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients
NCT01212614 ·Status: COMPLETED ·Phase: NA
-
Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux
NCT00231881 ·Status: UNKNOWN
-
Heartburn, Gastroesophageal Reflux Disease
NCT07268820 ·Status: RECRUITING ·Phase: PHASE4
-
Biology in Patients With Reflux Esophagitis
NCT01194323 ·Status: COMPLETED
-
Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)
NCT03228407 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)
NCT03184324 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease
NCT03811080 ·Status: UNKNOWN ·Phase: PHASE3